nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—Upset stomach—Metformin—polycystic ovary syndrome	0.041	0.0541	CcSEcCtD
Rifaximin—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0332	0.0437	CcSEcCtD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.0321	0.133	CbGpPWpGaD
Rifaximin—Contusion—Metformin—polycystic ovary syndrome	0.0308	0.0406	CcSEcCtD
Rifaximin—Ear pain—Metformin—polycystic ovary syndrome	0.0229	0.0301	CcSEcCtD
Rifaximin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.02	0.0263	CcSEcCtD
Rifaximin—Pain in extremity—Metformin—polycystic ovary syndrome	0.0195	0.0257	CcSEcCtD
Rifaximin—Migraine—Metformin—polycystic ovary syndrome	0.0192	0.0253	CcSEcCtD
Rifaximin—Dehydration—Metformin—polycystic ovary syndrome	0.0182	0.0239	CcSEcCtD
Rifaximin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0178	0.0235	CcSEcCtD
Rifaximin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0175	0.023	CcSEcCtD
Rifaximin—Abdominal distension—Metformin—polycystic ovary syndrome	0.017	0.0224	CcSEcCtD
Rifaximin—Sweating increased—Metformin—polycystic ovary syndrome	0.0164	0.0216	CcSEcCtD
Rifaximin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0162	0.0213	CcSEcCtD
Rifaximin—Neutropenia—Metformin—polycystic ovary syndrome	0.0158	0.0208	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0157	0.0207	CcSEcCtD
Rifaximin—Infestation NOS—Metformin—polycystic ovary syndrome	0.015	0.0198	CcSEcCtD
Rifaximin—Infestation—Metformin—polycystic ovary syndrome	0.015	0.0198	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptors—PGR—polycystic ovary syndrome	0.0137	0.0571	CbGpPWpGaD
Rifaximin—Rhinitis—Metformin—polycystic ovary syndrome	0.0135	0.0178	CcSEcCtD
Rifaximin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0134	0.0177	CcSEcCtD
Rifaximin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0133	0.0175	CcSEcCtD
Rifaximin—Flushing—Metformin—polycystic ovary syndrome	0.0125	0.0165	CcSEcCtD
Rifaximin—Angiopathy—Metformin—polycystic ovary syndrome	0.0123	0.0161	CcSEcCtD
Rifaximin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0122	0.016	CcSEcCtD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.012	0.0501	CbGpPWpGaD
Rifaximin—Malnutrition—Metformin—polycystic ovary syndrome	0.0118	0.0155	CcSEcCtD
Rifaximin—Flatulence—Metformin—polycystic ovary syndrome	0.0116	0.0153	CcSEcCtD
Rifaximin—Muscle spasms—Metformin—polycystic ovary syndrome	0.0113	0.0149	CcSEcCtD
Rifaximin—Tremor—Metformin—polycystic ovary syndrome	0.011	0.0145	CcSEcCtD
Rifaximin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0109	0.0144	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.0109	0.0451	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—AR—polycystic ovary syndrome	0.0107	0.0444	CbGpPWpGaD
Rifaximin—Malaise—Metformin—polycystic ovary syndrome	0.0106	0.014	CcSEcCtD
Rifaximin—Syncope—Metformin—polycystic ovary syndrome	0.0105	0.0139	CcSEcCtD
Rifaximin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0103	0.0136	CcSEcCtD
Rifaximin—Chest pain—Metformin—polycystic ovary syndrome	0.01	0.0132	CcSEcCtD
Rifaximin—Myalgia—Metformin—polycystic ovary syndrome	0.01	0.0132	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00994	0.0131	CcSEcCtD
Rifaximin—Discomfort—Metformin—polycystic ovary syndrome	0.00989	0.013	CcSEcCtD
Rifaximin—Infection—Metformin—polycystic ovary syndrome	0.00953	0.0126	CcSEcCtD
Rifaximin—Shock—Metformin—polycystic ovary syndrome	0.00944	0.0124	CcSEcCtD
Rifaximin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00941	0.0124	CcSEcCtD
Rifaximin—Skin disorder—Metformin—polycystic ovary syndrome	0.00932	0.0123	CcSEcCtD
Rifaximin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00928	0.0122	CcSEcCtD
Rifaximin—Anorexia—Metformin—polycystic ovary syndrome	0.00915	0.012	CcSEcCtD
Rifaximin—Hypotension—Metformin—polycystic ovary syndrome	0.00897	0.0118	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00874	0.0115	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.00864	0.0359	CbGpPWpGaD
Rifaximin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00856	0.0113	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.00844	0.0351	CbGpPWpGaD
Rifaximin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00834	0.011	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00828	0.0109	CcSEcCtD
Rifaximin—Fatigue—Metformin—polycystic ovary syndrome	0.00827	0.0109	CcSEcCtD
Rifaximin—Constipation—Metformin—polycystic ovary syndrome	0.00821	0.0108	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.0082	0.0341	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.0082	0.0341	CbGpPWpGaD
Rifaximin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00791	0.0104	CcSEcCtD
Rifaximin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00785	0.0103	CcSEcCtD
Rifaximin—Urticaria—Metformin—polycystic ovary syndrome	0.00762	0.01	CcSEcCtD
Rifaximin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00759	0.00999	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00731	0.0304	CbGpPWpGaD
Rifaximin—Asthenia—Metformin—polycystic ovary syndrome	0.00688	0.00907	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.00683	0.0284	CbGpPWpGaD
Rifaximin—Pruritus—Metformin—polycystic ovary syndrome	0.00679	0.00894	CcSEcCtD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.0067	0.0279	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00669	0.0278	CbGpPWpGaD
Rifaximin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00657	0.00865	CcSEcCtD
Rifaximin—Dizziness—Metformin—polycystic ovary syndrome	0.00635	0.00836	CcSEcCtD
Rifaximin—Vomiting—Metformin—polycystic ovary syndrome	0.0061	0.00803	CcSEcCtD
Rifaximin—Rash—Metformin—polycystic ovary syndrome	0.00605	0.00797	CcSEcCtD
Rifaximin—Dermatitis—Metformin—polycystic ovary syndrome	0.00604	0.00796	CcSEcCtD
Rifaximin—Headache—Metformin—polycystic ovary syndrome	0.00601	0.00792	CcSEcCtD
Rifaximin—Nausea—Metformin—polycystic ovary syndrome	0.0057	0.00751	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00529	0.022	CbGpPWpGaD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00516	0.0214	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.00449	0.0187	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ZNF205—polycystic ovary syndrome	0.00395	0.0164	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ZNF430—polycystic ovary syndrome	0.00395	0.0164	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00371	0.0154	CbGpPWpGaD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00339	0.0141	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ADARB1—polycystic ovary syndrome	0.00336	0.014	CbGpPWpGaD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00324	0.0135	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00313	0.013	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—LSM5—polycystic ovary syndrome	0.00274	0.0114	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SAP30L—polycystic ovary syndrome	0.00254	0.0106	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00224	0.00929	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—TEAD2—polycystic ovary syndrome	0.00216	0.00899	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.00215	0.00892	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00204	0.0085	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.00187	0.00779	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00186	0.00774	CbGpPWpGaD
Rifaximin—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00171	0.00711	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00165	0.00684	CbGpPWpGaD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00158	0.00657	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPL37A—polycystic ovary syndrome	0.00154	0.00641	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.00146	0.00606	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.00127	0.0053	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.0012	0.00498	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00118	0.00491	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.00118	0.0049	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00112	0.00466	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00111	0.00463	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0011	0.00457	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00109	0.00453	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—YAP1—polycystic ovary syndrome	0.00103	0.0043	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000971	0.00404	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000913	0.0038	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000912	0.00379	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000903	0.00375	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PGR—polycystic ovary syndrome	0.000903	0.00375	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000881	0.00366	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000879	0.00365	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00087	0.00362	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000846	0.00352	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000823	0.00342	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000714	0.00297	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00071	0.00295	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AR—polycystic ovary syndrome	0.000702	0.00292	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000701	0.00291	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000624	0.00259	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NCOR1—polycystic ovary syndrome	0.000614	0.00255	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000582	0.00242	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000576	0.00239	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000574	0.00239	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR3C1—polycystic ovary syndrome	0.000568	0.00236	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00053	0.0022	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000516	0.00214	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000509	0.00211	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00048	0.002	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00048	0.00199	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000473	0.00197	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARG—polycystic ovary syndrome	0.00044	0.00183	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000429	0.00178	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000396	0.00165	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000379	0.00158	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000374	0.00156	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000306	0.00127	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000302	0.00125	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000269	0.00112	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000246	0.00102	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000246	0.00102	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000229	0.000951	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000228	0.000948	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000195	0.000809	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000195	0.000809	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000163	0.000678	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000155	0.000642	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000147	0.000613	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000131	0.000546	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000125	0.000521	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000114	0.000475	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000112	0.000464	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000108	0.00045	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.96e-05	0.000414	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.64e-05	0.000401	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	9.3e-05	0.000386	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.93e-05	0.000371	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.82e-05	0.000367	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	8.33e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.2e-05	0.000341	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.1e-05	0.000295	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.9e-05	0.000287	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.49e-05	0.00027	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.79e-05	0.000241	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.52e-05	0.000229	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.23e-05	0.000217	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.88e-05	0.000203	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.95e-05	0.000164	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.9e-05	0.000162	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.88e-05	0.000161	CbGpPWpGaD
